Accendra Health, Inc. (FRA:6OM)

Accendra Health Statistics

Total Valuation

Accendra Health has a market cap or net worth of EUR 169.34 million. The enterprise value is 1.77 billion.

Market Cap	169.34M
Enterprise Value	1.77B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	76.44M
Shares Outstanding	n/a
Shares Change (YoY)	+0.20%
Shares Change (QoQ)	-0.76%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	60.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	4.63
PS Ratio	0.07
PB Ratio	-0.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.68, with an EV/FCF ratio of -7.08.

EV / Earnings	-1.88
EV / Sales	0.75
EV / EBITDA	4.68
EV / EBIT	14.23
EV / FCF	-7.08

Financial Position

The company has a current ratio of 0.58

Current Ratio	0.58
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	4.87
Debt / FCF	-7.39
Interest Coverage	1.28

Financial Efficiency

Return on equity (ROE) is -163.79% and return on invested capital (ROIC) is 9.14%.

Return on Equity (ROE)	-163.79%
Return on Assets (ROA)	2.57%
Return on Invested Capital (ROIC)	9.14%
Return on Capital Employed (ROCE)	9.72%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	361,911
Profits Per Employee	-144,218
Employee Count	23,200
Asset Turnover	0.78
Inventory Turnover	20.74

Taxes

In the past 12 months, Accendra Health has paid 620,889 in taxes.

Income Tax	620,889
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-73.33%
50-Day Moving Average	2.04
200-Day Moving Average	4.25
Relative Strength Index (RSI)	40.79
Average Volume (20 Days)	134

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.32

Income Statement

In the last 12 months, Accendra Health had revenue of EUR 2.35 billion and -937.42 million in losses. Loss per share was -12.19.

Revenue	2.35B
Gross Profit	1.10B
Operating Income	124.53M
Pretax Income	-86.83M
Net Income	-937.42M
EBITDA	307.24M
EBIT	124.53M
Loss Per Share	-12.19

Balance Sheet

The company has 240.17 million in cash and 1.84 billion in debt, with a net cash position of -1.60 billion.

Cash & Cash Equivalents	240.17M
Total Debt	1.84B
Net Cash	-1.60B
Net Cash Per Share	n/a
Equity (Book Value)	-392.61M
Book Value Per Share	-5.14
Working Capital	-340.00M

Cash Flow

In the last 12 months, operating cash flow was -86.69 million and capital expenditures -162.64 million, giving a free cash flow of -249.33 million.

Operating Cash Flow	-86.69M
Capital Expenditures	-162.64M
Free Cash Flow	-249.33M
FCF Per Share	n/a

Margins

Gross margin is 46.68%, with operating and profit margins of 5.29% and -39.85%.

Gross Margin	46.68%
Operating Margin	5.29%
Pretax Margin	-3.69%
Profit Margin	-39.85%
EBITDA Margin	13.06%
EBIT Margin	5.29%
FCF Margin	n/a

Dividends & Yields

Accendra Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.20%
Shareholder Yield	-0.20%
Earnings Yield	-553.58%
FCF Yield	-147.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 1, 2010. It was a forward split with a ratio of 1.50002.

Last Split Date	Apr 1, 2010
Split Type	Forward
Split Ratio	1.50002

Scores

Accendra Health has an Altman Z-Score of 0.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.62
Piotroski F-Score	3